From latent to patent: rethinking prediction of tuberculosis

Lancet Respir Med. 2017 Apr;5(4):243-244. doi: 10.1016/S2213-2600(16)30419-2. Epub 2016 Dec 22.

¹ Amsterdam Institute for Global Health and Development and Department of Global Health, Academic Medical Center, Amsterdam, Netherlands; KNCV Tuberculosis Foundation, The Hague, Netherlands. Electronic address: f.cobelens@aighd.org.
² Amsterdam Institute for Global Health and Development and Department of Global Health, Academic Medical Center, Amsterdam, Netherlands; KNCV Tuberculosis Foundation, The Hague, Netherlands.
³ Radcliffe Department of Medicine, University of Oxford, United Kingdom; Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa.
⁴ IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁵ Global TB Programme, World Health Organization, Geneva, Switzerland.
⁶ WHO Collaborating centre for TB/HIV and TB elimination, University of Brescia, Brescia, Italy.

No abstract available

MeSH terms